N/A
N=594
Reduction in IV Associated Contamination
Post-operative Infections
Bottom Line
View on ClinicalTrials.gov: NCT01426217 ↗Enrolled (actual)
594
Serious AEs
0.0%
Results posted
Oct 2018
Primary outcome: Primary: Presence of Bacterial IV Stopcock Lumen Contamination — 41; 32 percent stopcock contamination rate
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Passive Bundle PSI (Problem Solving Innovations) Medical HubScrub, PSI Medical DocIt (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Primary completion
- Nov 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Presence of Bacterial IV Stopcock Lumen Contamination |
41; 32 | — |
| SECONDARY Presence of Positive Bacterial Culture in IV Stopcock Due to Effluent Contamination |
86 | — |
Summary
The purpose of this study is to investigate whether implementing a novel syringe and IV stopcock cap system impregnated with alcohol will reduce IV catheter bacterial contamination and infections in patients.
Eligibility Criteria
Inclusion Criteria
- Adult patient undergoing surgery or procedure in operating room
- Undergoing general anesthesia
Exclusion Criteria
- Children (age < 18 years)
- Lack of intravenous access
- failure of anesthesia provider to complete training on experimental device
Data sourced from ClinicalTrials.gov (NCT01426217). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.